Neuramedy Co. Ltd.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 Single Ascending Dose Study (NCT06934941) | Neuramedy Co. Ltd. | 2024-11-25 |
| Single and Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of NM-101 (NCT05790382) | Neuramedy Co. Ltd. | 2023-05-10 |
Track Neuramedy Co. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.